Purpose: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is the most reliable method for the histological diagnosis of pancreatic tumors. Rapid on-site fluorescence-guided histological diagnosis was evaluated by topically applying an enzymatically activatable probe onto the EUS-FNA samples; the probe fluoresces in the presence of γ-glutamyltranspeptidase (GGT). Procedures: We evaluated GGT expression in pancreatic cancer cell lines in vitro. EUS-FNA was performed in 10 pancreatic tumors. After topical application of the probe, signal intensity was measured using a fluorescence imaging system for 13 min. Results: GGT was expressed in Panc-1, AsPC-1, and AR42J, but not in KP4 cells. In samples from six cases, several regions of the specimens fluoresced and contained adequate tissue for pathological diagnosis. The remaining four non-fluorescent samples contained very small amounts of carcinoma, normal epithelial cells, or no epithelial cells. The signal intensity at 5 min was 25.5±7.7 and 7.7±0.5 in fluorescent and non-fluorescent regions, respectively (pG0.05). Conclusions: Application of enzymatically activatable probe onto EUS-FNA samples would be feasible for the rapid evaluation of tissues suitable for histological diagnosis.
Introduction
Pancreatic cancer is the fourth most common cause of cancer death in men and women [1] . Endoscopic ultrasound-guided C o r r e s p o n d e n c e t o : S h u n s u k e O h n i s h i ; e -m a i l : sonishi@pop.med.hokudai.ac.jp, Yasuteru Urano; e-mail: uranokun@m.utokyo.ac.jp (2016) fine needle aspiration (EUS-FNA) is a commonly used method for definitive tissue diagnosis of pancreatic cancer with high sensitivity and specificity [2] . In EUS-FNA, however, endoscopists perform a variable number of needle passes to increase the probability of obtaining an adequate sample at the expense of adverse events such as pancreatitis and bleeding [3, 4] . Rapid on-site evaluation during EUS-FNA improves the diagnostic yield, decreasing the number of unsatisfactory samples and reducing the need for additional passes [5, 6] . However, intensive training is necessary for accurate interpretation of tissue specimens and histological diagnosis [7, 8] .
Recently, several target-activatable optical imaging methods have been developed for cancer detection [9] [10] [11] . We have previously reported a rapid-cancer detection m e t h o d i n v o l v i n g t o p i c a l s p r a y i n g o f a γ -glutamyltranspeptidase (GGT)-activated fluorescent probe, γ-glutamyl hydroxymethyl rhodamine green (gGlu-HMRG) in vivo; this probe becomes fluorescent after cleavage of a GGT-specific sequence [12] . The detection of colon cancer using fluorescence after topical administration (spraying) of gGlu-HMRG has been reported in mice and resected human specimens [13, 14] . In contrast, GGT was expressed not only in the pancreatic cancer cells but also in the normal pancreatic acinar cells [15] [16] [17] . Therefore, we hypothesized that gGlu-HMRG was useful for the detection of pancreatic tissue specimens obtained by EUS-FNA.
Here, we applied gGlu-HMRG for the detection of adequate tissue specimens regarding EUS-FNA and determined the feasibility of this method for rapid on-site detection of pancreatic tumors.
Materials and Methods

Enzymatic-Activatable Fluorescent Probe
The gGlu-HMRG probe was synthesized as previously reported, dissolved in dimethyl sulfoxide (10 mM), and stored at −80°C until used [12] . Briefly, gGlu-HMRG is non-fluorescent under a normal environment without GGT activity. When gGlu-HMRG reacts with GGT on the surface of cancer cells or specimens, it is immediately hydrolyzed and transformed into HMRG, showing strong fluorescence. The gGlu-HMRG probe was dissolved and diluted with phosphate-buffered saline (PBS; Life Technologies, Carlsbad, CA, USA) to 1 and 100 μM at 1 h before application to cell culture and EUS-FNA samples, respectively.
Cell Experiments
Cell Culture The human pancreatic cancer cell lines AsPC-1, PANC-1, and KP4 and rat AR42J pancreatic acinar cells were used to investigate GGT expression. The AsPC-1 cell line was obtained from Dainippon Sumitomo Pharmaceuticals (Osaka, Japan), and the PANC-1 and AR42J cell lines were obtained from the European Collection of Cell Cultures; they were cultured in RPMI 1640 (Life Technologies) supplemented with 10 % fetal bovine serum (FBS; Life Technologies) and 100 U/ml penicillin and 100 μg/ml streptomycin (Life Technologies). The KP4 cell line was obtained from RIKEN BRC through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan, and cultured in DMEM/F12 (Life Technologies) supplemented with 10 % FBS and 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were cultured in culture flasks in a humidified incubator at 37°C at an atmosphere of 95 % air and 5 % CO 2 .
Fluorescence Microscopy Cells were cultured in a 35-mm dish and incubated for 24 h. After cells were washed with PBS, 1 μM of gGlu-HMRG in PBS was added and incubated in the dark for 20 min at 37°C. Then, fluorescence microscopy was performed using a Biorevo BZ-9000 microscope (Keyence, Osaka, Japan), equipped with the following filters: excitation wavelength, 450-490 nm and emission wavelength, 500-550 nm. Phase contrast images were also acquired. 
Flow Cytometry
Human Clinical Studies
Endoscopic Ultrasound-Guided Fine Needle Pancreatic Tissue Acquisition Endoscopic ultrasound-guided fine needle tissue acquisition was performed under conscious sedation with intravenous midazolam and fentanyl using linear echoendoscope (GF-UCT 240-AL5: Olympus Ltd., Tokyo, Japan). After confirming that there were no intervening vessels, pancreatic solid lesions were punctured using 22-or 19-gauge needles (Echotip: Cook Medical Inc., Bloomington, IN, USA) followed by 10-20 to-and-fro movements with continuous negative pressure provided by a 10-ml syringe.
On-Site Tissue Evaluation using Fluorescence Imaging After the needle had been withdrawn, the stylet was reintroduced and the specimen was pushed out onto a slide glass. Then, 100 μM of gGlu-HMRG in PBS was applied to the specimen to cover the whole surface. Immediately after the application, the specimen was examined under a handheld fluorescent imaging system (Discovery: INDEC Medical Systems, Santa Clara, CA, USA), which provided captured white light and fluorescent images with 450-490 nm blue excitation light for 13 min. After fluorescence evaluation, the specimen was collected and fixed in 10 % formalin for histological analysis. We measured the signal intensity in the fluorescent regions of the specimens and the non-fluorescent specimens using the Image J software (National Institutes of Health, Rockville, MD, USA) every 1 min over a period of 13 min.
Histological Analysis Histological analysis was performed by a single expert pathologist (K.H.) who was blinded to the clinical data, based on hematoxylin and eosin staining. In each sample, the quantity was assessed using the scoring system as previously reported [18] . Briefly, the scoring system was as follows: score 0, insufficient material; score 1, sufficient material for limited cytological interpretation; score 2, sufficient materials for adequate cytological interpretation; score 3, sufficient material for limited histological interpretation; score 4, sufficient material for adequate histological interpretation with low quality; and score 5, sufficient material for adequate histological interpretation with high quality. The proportion of adequate tissue samples was defined as number of adequate tissue samples (adequacy score of ≥3) divided by the total number of tissue samples. Fisher's exact test was applied to the difference in proportion between fluorescent and non-fluorescent regions.
Immunohistochemistry Immunohistochemistry was performed to examine GGT expression in each EUS-FNA sample. In patients who underwent surgical resection, GGT expression was also evaluated in the resected specimens. Slides were deparaffinized in xylene and sequentially washed in 100, 95, 75, and 50 % ethanol and subsequently washed in PBS. After heat-induced antigen retrieval (citrate at pH 6), the slides were preincubated in 1 % H 2 O 2 followed by incubation in blocking solution (normal goat serum) for 2 h. The slide was then incubated in primary anti-GGT1 antibody (Abcam, Cambridge, MA, USA) at 4°C overnight at a dilution of 1:1000, followed by a biotin-conjugated secondary antirabbit antibody (Vector Labs, Burlingame, CA, USA) with a dilution of 1:200 to amplify the signal, resulting in greater sensitivity. The slides were then incubated with an ABC reagent (Vectorstain ABC Kit: Vector Labs) for 30 min. The adequacy score was calculated as detailed in a previous report [18] b Signal intensity of the fluorescent region at 13 min
Results
GGT Expression in Pancreatic Cancer Cells
We first evaluated gGlu-HMRG fluorescence in three pancreatic cancer cell lines (AsPC-1, PANC-1, and KP4) and pancreatic acinar cells (AR42J) to determine GGT expression. Using fluorescence microscopy, gGlu-HMRG fluorescence was detected in the AsPC-1, PANC-1, and AR42J cells, but not in KP4 cells (Fig. 1a) . Flow cytometric analysis also revealed GGT expression in PANC-1, AsPC-1, and AR42J cells, but not in KP4 cells (Fig. 1b) . SBR was 13.2, 3.8, 1.4, and 2.5 in AsPC-1, PANC-1, KP4, and AR42J cells, respectively.
Detection of Adequate Tumor Tissue in EUS-FNA Samples Using Fluorescence Microscopy
We performed EUS-FNA on 10 patients with pancreatic tumors (Table 1) . After gGlu-HMRG was applied topically (sprayed) onto the EUS-FNA samples, several regions of the specimens (six samples) immediately exhibited fluorescence; the remaining four samples did not exhibit fluorescence over the 13-min observation period. Fluorescent specimens contained adequate tissue for pathological diagnosis, and their adequacy score was ≥2. The use of EUS-FNA led to the accurate diagnosis of pancreatic tumor in all of the specimens. Non-fluorescent specimens contained a very small amount of carcinoma, normal epithelial cells, acinar cells, or no epithelial cells, and their adequacy score was ≤2. The proportion of adequate tissue materials (adequacy score ≥3) was 83 and 0 % in fluorescent and non-fluorescent specimens, respectively (p=0.048).
Fluorescence Intensity of the EUS-FNA Samples
The time-course of the fluorescent images for cases 4 and 5 are shown in Fig. 2a , and the signal intensities in the fluorescent and non-fluorescent regions in six fluorescent samples are shown in Fig. 2b . Mean signal intensity in the fluorescent regions was 25.5±7.7 at 5 min after administration. In the six samples with fluorescent regions, architecturally intact pieces of tissue sufficient for histological evaluation of the targeted lesion were confirmed. Histological diagnoses of the EUS-FNA samples were five pancreatic adenocarcinomas and one neuroendocrine tumor (Table 1) . In contrast, non-fluorescent samples were not sufficient for histological evaluation and contained normal epithelial cells or no epithelial cells. In two patients, no adequate tissue samples were obtained. One of these patients had epithelial cells with no atypia, and another had a small amount of atypical cells. The mean signal intensity in the nonfluorescent regions was 7.7±0.5 at 5 min after administration. The difference of signal intensity between fluorescent and non-fluorescent part became significant 5 min after the application of gGlu-HMRG.
Three Representative Cases
Case 4: Pancreatic Adenocarcinoma EUS-FNA was performed on a 63-year-old male with a pancreatic body tumor (Fig. 3a) . Several regions of the specimen exhibited fluorescence immediately after spraying of gGlu-HMRG (Fig. 3b) . Histological examination of the fluorescent regions demonstrated that the tissue contained a number of tumor cells expressing GGT (Fig. 3c) . In contrast, there were a small number of tumor cells that expressed GGT within the numerous red blood cells in the nonfluorescent regions (Fig. 3d) . The histological adequacy score was 5. 
Case 6: Focal Pancreatitis
EUS-FNA was undertaken on a 57-year-old female with a pancreatic body tumor (Fig. 4a) . After gGlu-HMRG administration, the specimen did not become fluorescent (Fig. 4b) . Histological examination of the specimen demonstrated that there was only a small number of epithelial cells without atypia within the numerous red blood cells (Fig. 4c) . During the 1-year follow-up, the diameter and appearance of this tumor were unchanged. The histological adequacy score was 2.
Case 10: Pancreatic Neuroendocrine Tumor
A 77-year-old female with pancreatic tail tumor underwent EUS-FNA (Fig. 5a ). Several parts of the specimen became fluorescent after the spraying of gGlu-HMRG (Fig. 5b) . Histological examination of the fluorescent regions demonstrated that the tissue contained atypical cells with oval nuclear and pancreatic acinar cells expressing GGT (Fig. 5c) . The patient received distal pancreatectomy, and the surgical specimens revealed a neuroendocrine cell tumor that weakly expressed GGT (Fig. 5d) . The histological adequacy score was 3.
Discussion
In the present study, we evaluated a novel technology for the immediate detection of adequate EUS-FNA specimens of pancreatic neoplasm based on an enzymatically activatable fluorescent probe (gGlu-HMRG), which was rapidly activated by GGT. Although GGT was highly expressed in the whole pancreas, especially in the normal acinar cells, the fluorescent regions correlated with adequate specimens of pancreatic tumors leading to accurate diagnosis. This technique could not only minimize the number of needle punctures required without adversely affecting pathological diagnosis but could also be used in place of rapid on-site evaluation involving cytopathologists. As described in this study, GGT was expressed in the acini of the normal pancreas as demonstrated using immunohistochemistry. Our in vitro study also demonstrated that AR42J rat acinar cells expressed GGT. This was consistent with the findings of previous studies [15] [16] [17] . Recently, GGT expression has also been used for the visualization of the leakage of pancreatic juice using gGlu-HMRG [19] . GGT has been reported to be expressed at higher levels in various cancer cells than in normal cells or in inflammation [13, 20] . In the present study, AsPC-1 and PANC-1 cells expressed GGT, but KP4 cells did not. This finding was consistent with previous reports that GGT fluorescent activity was enhanced in approximately 60 % of the cultured cancer cells [21] . GGT has been reported to be overexpressed in several human cancer cells and is considered to be a potential biomarker for early cancer detection [22] [23] [24] . Recently, topical spraying of gGlu-HMRG has been demonstrated to be useful for the selective fluorescent imaging of colorectal tumors owing to the upregulated GGT activity [14] . Our study demonstrated that pancreatic ductal adenocarcinoma strongly expressed GGT and that gGlu-HMRG was useful for the detection of adequate specimens of pancreatic cancer. However, immunohistochemical analysis revealed that GGT was not strongly expressed in neuroendocrine tumor cells as compared with normal acinar cells. Therefore, the effectiveness of gGlu-HMRG regarding the rapid diagnosis of pancreatic neuroendocrine tumors remained undetermined.
In EUS-FNA of pancreatic tumors, adequate specimens are necessary for accurate histological diagnosis [25] . To improve the diagnostic ability of EUS-FNA, rapid on-site evaluation using Diff-Quick staining is performed by a cytopathologist or an endosonographer [5, 26, 27] . However, this procedure costs time and money, and intensive training is necessary for improving accuracy [8, 28] . Recently, the use of macroscopic on-site evaluation involving 19-gauge needle EUS-FNA has been reported; however, 19-gauge needle puncture is sometimes difficult, especially for pancreatic head lesions [29, 30] . Using our novel technique, adequate tissue samples obtained using both 19-and 22-gauge needles could be visualized within 5 min after probe application. However, because gGlu-HMRG was not found to be highly specific regarding the detection of pancreatic cancer tissue in EUS-FNA samples, contamination by normal acinar cells could not be excluded. Recently, tumor-specific in vitro imaging using adenovirus-mediated gene transfection-induced telomerase promoter-regulated expression of fluorescent proteins has been reported [31, 32] . Although this technique might lead to more specific cancer diagnosis, it is not possible to apply it to rapid on-site cancer diagnosis within 5 min as is the case with gGlu-HMRG.
The current study had several limitations. gGlu-HMRG did not clearly differentiate pancreatic tumor tissues from normal pancreatic ones because GGT activity was not different between tumor cells and normal cells. The number of patients was relatively small, and use of this probe needs to be evaluated prospectively in studies involving large numbers of patients. In addition, we only evaluated two types of pancreatic tumor, pancreatic ductal adenocarcinoma and neuroendocrine tumor. EUS-FNA is widely used in the histological diagnosis of pancreatic tumors, and lymph node and gastrointestinal submucosal tumors [26, 33, 34] . The effectiveness of novel on-site evaluation regarding other tumor types remains unknown; however, the application of gGlu-HMRG could have a clinical impact concerning the rapid on-site evaluation of EUS-FNA specimens.
Conclusions
Application of enzymatically rapid-activatable fluorescent probe to EUS-FNA samples would be a reliable method for the immediate detection of adequate tissue materials suitable for histological diagnosis. This technique could minimize the number of needle punctures required, without the expense associated with conventional pathological diagnosis.
